Transrectal ultrasound imaging and prostate cancer

Archivio Italiano di Urologia e Andrologia

Volumn 75, Issue 1, 2003, Pages 68-74

  Goossen, Tjerk ^a   Wijkstra, Hessel ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Doppler ultrasound; Prostate cancer; Techniques; Transrectal ultrasound; Ultrasound imaging

Indexed keywords

CANCER DIAGNOSIS; COLOR ULTRASOUND FLOWMETRY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; GRAY SCALE ECHOGRAPHY; HUMAN; MALE; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

ADENOCARCINOMA; CONTRAST MEDIA; FORECASTING; HUMANS; MALE; PERFUSION; PROSTATIC NEOPLASMS; RECTUM; ULTRASONOGRAPHY; ULTRASONOGRAPHY, DOPPLER;

EID: 0037368312     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2001. CA Cancer J Clin 2001; 51:15
2. Djavan B, Zlotta A, Kratzik C et al. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 L. Urology 1999; 54:517
3. Mitchell ID, Croal BL, Dickie A, Cohen NP, Ross I. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. J Urol 2001; 165:1549
4. Schroder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R. Prostate-specific antigen-based early detection of prostate cancer-validation of screening without rectal examination. Urology 2001; 57:83
5. Chang JJ, Shinohara K, Bhargava V, Presti JC, Jr. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998; 160:2111
6. Perrotti M, Pantuch A, Rabbani F, Israeli RS, Weiss RE. Review of staging modalities in clinically localized prostate cancer. Urology 1999; 54:208
7. Wilkinson BA, Hamdy FC. State-of-the-art staging in prostate cancer BJU Int 2001; 87:423
8. Engelbrecht MR, Barentsz JO, Jager GJ et al. Prostate cancer staging using imaging. BJU Int 2000; 86:123
9. Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50:562
10. Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 2000; 163:1144; discussion 8-9
11. Djavan B, Mazal P, Zlotta A, et al. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 2001; 47:111
12. Roehrborn CG, Pichens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels. Urology 1996; 47:347
13. Lerner SE, Blute ML, Zincke H. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 1995; 154:1447
14. Gerber GS, Thisted RA, Chodak GW, et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 1997; 32:385
15. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 1990; 143:538; discussion 44
16. Hering F, Rist M, Roth J, Mihatsch M, Rutishauser G. Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? Br J Urol 1990; 66:177
17. Sebo TJ, Cheville JC, Riehle DL, et al. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 2001; 91:2196
18. Gilliland FD, Hoffman RM, Hamilton A, et al. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol 1999; 162:1341
19. Grossfeld GD, Chang JJ, Broering JM, et al. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001; 165:851
20. Fernandes ET, Sundaram CP, Long R, Soltani M, Ercole CJ. Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? Br J Urol 1997; 79:615
21. Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 1989; 142:76
22. Egawa S, Wheeler TM, Greene DR, Scardino PT. Unusual hyperechoic appearance of prostate cancer on transrectal ultrasonography. Br J Urol 1992; 69:169
23. Hendrikx AJ, de la Rosette JJ, van Helvoort-van Dommelen CA, et al. Histological analysis of ultrasonic images of the prostate: an accurate technique. Ultrasound Med Biol 1990; 16:667
24. Cornud F, Belin X, Piron D, et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997; 49:709
25. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 2000; 174:623
26. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24:68
27. Singh G, Lakkis CL, Laucirica R, Epner DE. Regulation of prostate cancer cell division by glucose. J Cell Physiol 1999; 180:431
28. Bustamante E, Morris HP, Pedersen PL. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 1981; 256:8699
29. Mathupala SP, Rempel A, Pedersen PL. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 2001; 276:43407
30. Costello LC, Franklin RB. The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 2000; 59:269
31. Movsas B, Chapman JD, Horwitz EM, et al. Hypoxic regions exist in human prostate carcinoma. Urology 1999; 53:11
32. Movsas B, Chapman JD, Greenberg RE, et al. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. Cancer 2000; 89:2018
33. Cvetkovic D, Movsas B, Dicker AP, et al. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 2001; 57:821
34. Siegal JA, Yu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995; 75:2545
35. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78:940
36. Rubin MA, Buyyounouski M, Bagiella E, et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 1999; 53:542
37. Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1997; 79:772
38. Cornud F, Hamida K, Flam T, et al. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 2000; 175:1161
39. Shigeno K, Igawa M, Shiina H, Wada H, Yoneda T. The role of colour Doppler ultrasonography in detecting prostate cancer. BJU Int 2000; 86:229
40. Louvar E, Littrup PJ, Goldstein A, et al. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83:135
41. Unal D, Sedelaar JP, Aarnink RG, et al. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 2000; 86:58
42. Franco OE, Arima K, Yanagawa M, Kawamura J. The usefulness of power Doppler ultrasonography for diagnosing prostate cancer: histological correlation of each biopsy site. BJU Int 2000; 85: 1049
43. Okihara K, Kojima M, Nakanouchi T, Okada K, Miki T. Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int 2000; 85:1053
44. Bree RL. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 1997; 49:31
45. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968; 3:356
46. Mayer S, Grayburn PA. Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis 2001; 44:33
47. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48:232
48. Tiemann K, Pohl C, Schlosser T, et al. Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of nonmoving microbubbles. Ultrasound Med Biol 2000; 26:1161
49. Dayton PA, Morgan KE, Klibanov AL, Brandenburger GH, Ferrara KW. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999; 46:220
50. Kamiyama N, Moriyasu F, Mine Y, Goto Y. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 1999; 25:411
51. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced us for detection. Radiology 2001; 219:219
52. Bogers HA, Sedelaar JPM, Beerlage HP, et al. Contrast-enhanced three-dimensional power doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54:97
53. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002; 167:1648
54. Sedelaar JP, van Leenders GJ, Hulsbergen-Van De Kaa CA, et al. Microvessel Density: Correlation between Contrast Ultrasonography and Histology of Prostate Cancer. Eur Urol 2001; 40:285
55. Aarnink RG, Beerlage HP, de la Rosette JJ, Debruyne FM, Wijkstra H. Contrast angiosonography: a technology to improve Doppler ultrasound examinations of the prostate. Eur Urol 1999; 35:9
56. Eckersley R, Cosgrove D, Blomley M, Hashimoto H. Functional imaging of tissue response to bolus injection of ultrasound contrast agent. Proceedings of the IEEE Ultrasonics symposium 1998;1779
57. Goossen TEB, Sedelaar JPM, de la Rosette JJMCH, van Leenders GJLH, Wijkstra H. The value of dynamic contrast enhanced power doppler ultrasound in the localization of prostate carcinoma, Abstract 355, Eur Urol (Suppl 1), 2002; 1:91
58. Basude R, Wheatley MA. Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages. Ultrasonics 2001; 39:437
59. Bouakaz A, Frigstad S, Ten Cate FJ, de Jong N. Super harmonic imaging: a new imaging technique for improved contrast detection. Ultrasound in Medicine & Biology 2002; 28:59
60. Hope Simpson D, Chin CT, Burns PN. Pulse inversion Doppler: A new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999; 46:372
61. Wei K, Jayaweem AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97:473
62. Villanueva FS, Gertz EW, Csikari M, et al. Detection of coronary artery stenosis with power Doppler imaging. Circulation 2001; 103:2624
63. Seidel G, Claassen L, Meyer K, Vidal-Langwasser M. Evaluation of blood flow in the cerebral microcirculation: analysis of the refill kinetics during ultrasound contrast agent infusion. Ultrasound Med Biol 2001; 27:1059
64. Halpern EJ, Verkh L, Forsberg F, et al. Initial experience with contrast-enhanced sonography of the prostate. AJR Am J Roentgenol 2000; 174:1575